Home › Free Stock Grades › LNTH
Lantheus Holdings, Inc. (LNTH) Stock Grade
LNTH · Healthcare
A+
Market Cap
$6.5B
P/E Ratio
19.2
Revenue Growth (YoY)
+0.5%
Net Margin
15.2%
Return on Equity
21.4%
Dividend Yield
None
About Lantheus Holdings, Inc.'s fundamentals
Lantheus Holdings is a specialty pharmaceutical company with a $6.5 billion market capitalization that demonstrates strong profitability, with a net margin of 15.2% and a return on equity of 21.4%, indicating efficient use of shareholder capital. The company trades at a P/E ratio of 19.2, which is moderate relative to the healthcare sector. However, revenue growth has been minimal at just 0.5% year-over-year, suggesting limited top-line expansion. The company does not currently pay a dividend to shareholders.